Sun Pharmaceuticals
Taro to merge with Sun Pharma in $350 million deal
21 Jan 2024
Sun Pharmaceutical Industries Limited and Israel-based Taro Pharmaceutical Industries Ltd have entered into a definitive merger agreement under which Sun Pharma
Sun Pharma chairman Israel Makov to retire on 29 August
08 Aug 2022
Makov has played a significant role in Sun Pharma’s transformation from a $1.7 billion organisation focusing on India and the US into the world's fourth largest specialty generic pharmaceutical company operating across 100+ markets with a turnover of over $5 billion
Sun Pharma swings to Q2 net profit of Rs1,062 cr
07 Nov 2019
Sun Pharma Halol unit gets 3 adverse notices from US FDA: shares rise
24 Feb 2018
Although the strictures will impact Sun Pharmaceutical’s US business, the bourses took a positive view with the company’s shares actually rising, as the number of observations has come from the earlier nine to just three
